CereVasc Inc
CereVasc is a medical device company focused on developing novel, minimally invasive treatments for neurological diseases, particularly hydrocephalus. Their flagship product, the eShunt System, aims to provide a minimally invasive alternative to traditional neurosurgical procedures, potentially reducing failure rates, complications, and costs associated with current treatments.
Industries
Nr. of Employees
small (1-50)
CereVasc Inc
100 1st Avenue, Building 39, Suite 403, Charlestown Navy Yard, Charlestown, Massachusetts 02129
Patents
Apparatus and methods for loading an endovascular implant into a delivery catheter
US-12064361-B2
View DetailsMethods and systems for draining cerebrospinal fluid into the venous system
US-12011557-B2
View Details
Apparatus and methods for loading an endovascular implant into a delivery catheter
US-12064361-B2
View DetailsMethods and systems for draining cerebrospinal fluid into the venous system
US-12011557-B2
View DetailsProducts
Investigational endovascular cerebrospinal fluid (CSF) shunt system
An investigational endovascularly implantable CSF shunt and delivery components designed to divert CSF via venous access to avoid open cranial surgery and reduce common failure modes associated with conventional ventriculo-peritoneal shunts.
Investigational endovascular cerebrospinal fluid (CSF) shunt system
An investigational endovascularly implantable CSF shunt and delivery components designed to divert CSF via venous access to avoid open cranial surgery and reduce common failure modes associated with conventional ventriculo-peritoneal shunts.
Services
Design and conduct of first-in-human, pilot and early-phase studies under regulatory approvals to evaluate safety and performance of an investigational endovascular CSF shunt.
Collaborative development opportunities for pharmaceutical and biotechnology companies to evaluate the platform for CNS drug or gene therapy delivery.
Design and conduct of first-in-human, pilot and early-phase studies under regulatory approvals to evaluate safety and performance of an investigational endovascular CSF shunt.
Collaborative development opportunities for pharmaceutical and biotechnology companies to evaluate the platform for CNS drug or gene therapy delivery.
Expertise Areas
- Endovascular device development
- Minimally invasive neurosurgical interventions
- Clinical trial design and execution for investigational devices
- Medical device regulatory strategy (IDE, Breakthrough Device pathways)
Key Technologies
- Endovascular implantation
- Percutaneous femoral venous access
- Fluoroscopic/X-ray guided angiographic deployment
- Biomimetic transdural valved shunt design